Maria Cecília Araripe Sucupira

Author

Also Known As

M C A Sucupira, M Sucupira, M. Cecilia A. Sucupira, M. Cecilia Sucupira, M. Cecília Sucupira, M. Sucupira, M.C. Araripe Sucupira, M.C. Sucupira, M.C.A. Sucupira, Maria C A Sucupira

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Universidade Federal de São Paulo Universidade de São Paulo Fundação Pró-Sangue Hemocentro de São Paulo University of California, San Francisco Universidade Federal do Rio de Janeiro

About

Maria Cecília Araripe Sucupira is an author at Universidade Federal de São Paulo specializing in hiv, medicine, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	560
2	Epidemiology	8	8	375
3	Public Health	5	5	212
4	Natural Sciences	1	1	24
5	Cell Biology	1	1	24

Maria Cecília Araripe Sucupira

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Differential Persistence of Transmitted HIV-1 Drug Resistance Mutation Classes Vivek Jain, Maria Cecília Araripe Sucupira, Peter Bacchetti, The Journal of Infectious Diseases	2011	139
Identification of Two HIV Type 1 Circulating Recombinant Forms in Brazil Dercy José de Sá Filho, Maria Cecília Araripe Sucupira, Marcos M. Casiero, AIDS Research and Human Retroviruses South AmericaViral EvolutionRecombinant FormsMedicineGenetics	2006	102
Brazilian Network for HIV Drug Resistance Surveillance: a survey of individuals recently diagnosed with HIV Lilian A. Inocêncio, Anderson Alvarenga Pereira, Maria Cecília Araripe Sucupira, Journal of the International AIDS Society Infectious Disease EpidemiologyTreatment And PreventionDrug ResistanceGlobal HealthMedicine	2009	87
High Levels of Primary Antiretroviral Resistance Genotypic Mutations And B/F Recombinants in Santos, Brazil Maria Cecília Araripe Sucupira, Marcos Montani Caseiro, Katia Alves, AIDS Patient Care and STDs Treatment And PreventionHuman RetrovirusGenetic EpidemiologyImmunologyB/f Recombinants	2007	59
Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment Bruno Scarpelini, Michelle Zanoni, Maria Cecília Araripe Sucupira, PLoS ONE	2016	50
Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial Ricardo Sobhie Diaz, Iart Luca Shytaj, Leila B. Giron, International Journal of Antimicrobial Agents Potential ImpactHuman RetrovirusImmunologyAntiviral TherapyAntiviral Response	2019	48
Significance of isolated hepatitis B core antibody in blood donors from São Paulo Cesar de Almeida‐Neto, Edna Strauss, Esther Cerdeira SABINO, Revista do Instituto de Medicina Tropical de São Paulo VaccinationImmunohematologyHbv MarkersHepatologyViral Hepatitis	2001	46
Prevalence, Incidence Density, and Genotype Distribution of GB Virus C Infection in a Cohort of Recently HIV-1-Infected Subjects in Sao Paulo, Brazil Maria Teresa Maidana Giret, João Luiz Miraglia, Maria Cecília Araripe Sucupira, PLoS ONE	2011	41
Establishment of the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion (STARHS) strategy in the city of São Paulo, Brazil Esper G. Kallás, Kátia Cristina Bassichetto, Solange Maria Oliveira, The Brazilian Journal of Infectious Diseases	2004	37
Faster HIV-1 Disease Progression among Brazilian Individuals Recently Infected with CXCR4-Utilizing Strains Maria Cecília Araripe Sucupira, Sabri Saeed Sanabani, Rodrigo Cortes, PLoS ONE	2012	33

Page 1